image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Ebiquity - Gain in two months: 68%

September 2009

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EBQ
  • Price:
  • 58p
Our decision to buy-rate media intelligence and advertising monitoring firm Ebiquity in the July issue of The Momentum Investor now looks well-timed with the shares quickly rising from 34.5p to 58p. The catalyst has been strong results for the year to 30 April, which showed underlying operating profit increasing 17% to £2.4m on turnover that increased 7% to £18.4m. Eps rose 20% to 5.28p. The larger Analytics division led the way with operating profit increasing an impressive 74% to £3.2m, helped by a 36% rise in revenue from international assignments. Its smaller Platform division, which was impacted by reduced renewals and one-off investment in new product launch, made an operating loss of £0.35m. Latest forecasts are ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X